Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Chinese Pharma Growth Almost Flat in Q2 as Government Heightens Cost Containment
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on interpreting recent pharmaceutical industry and market pe... (11/1/2018)
   
Production of Trustworthy Real World Data and Evidence in China (11/7/2018)
Issues in Chinese Foreign Direct Investment in U.S. Early Stage Biotechnology Companies (11/2/2018)
Chinese Pharma Growth Almost Flat in Q2 as Government Heightens Cost Containment (11/1/2018)
Innovent Biologics Believes It Can Help Usher in A 'Game Changer' for Drug Prices in China (11/1/2018)
Bispecific Antibodies in China (10/26/2018)
Alibaba and JD.com Operate in Grey Area with Online Drug Sales (10/25/2018)
Three Big Pharma Stocks Racing Along the Road to China (10/25/2018)
China Is Funding the Future of American Biotech (10/23/2018)
China's Pharmaceutical Firms Feel First Impact From Trump's Trade War (10/17/2018)
Targeting the Affluent: Differential Access to Targeted Therapies in China (10/16/2018)
How to Fulfil Chin'’s Potential for Carrying Out Clinical Trials (10/15/2018)
Exploring Ways to Establish Presence in China as Part of APAC Region Push: Lupin Pharma (10/15/2018)
China: AstraZeneca’s New Engine for Growth and Innovation (10/9/2018)
Biosimilars and Healthcare Policy: What China Can Learn from the EU and US (10/8/2018)
Why China Is Going All Out to Invent New, Stronger, Cheaper Drugs (10/8/2018)
SAMR Solicits Comments on Vaccine Admini...  (11/12/2018)
SAMR Solicits Comments on Production Lic...  (11/12/2018)
Guangdong Introduces Implementation Plan...  (11/12/2018)
China Step Up Crackdown on Medical Fraud...  (11/11/2018)
China Step Up Crackdown on Medical Fraud...  (11/11/2018)
Merck KGaA Paves the Way for its Innovat...  (11/11/2018)
Performance of Chinese Pharmaceutical In...  (11/9/2018)
Recent Executive Moves  (11/9/2018)
Amyris Further Expands Relationship with...  (11/8/2018) (free)
Ascendis Forms Chinese JV for Endocrinol...  (11/8/2018)
NMPA Issues Guidelines for Clinical Tria...  (11/8/2018)
NMPA Issues New Announcement (2018#86) f...  (11/8/2018)
Leading Chinese Pharma Companies by R&am...  (11/8/2018)
Shanghai Promotes Biopharma Innovation w...  (11/7/2018)
GE to Produce Single-Use Consumables in ...  (11/7/2018) (free)
Top 25 Global Pharmaceutical Companies by Market Cap 201...
CANbridge Receives IND Approval to Commence CAN008 Phase...
Global Contract Pharmaceutical Manufacturing Market to R...
White House Task Force Echoes Pharma Proposals
Pharma Industry Reputation Rebounds Somewhat in 2016
Faster Aging of Population Boosts China's Human Vaccine Industr...
DB6: Chinese OTC Market Up 6.6% in MAT Q2/2018
IQVIA: Chinese Retail Pharmacy Market Surged 3.9% in MAT Q2/201...
IQVIA: Chinese Hospital Drug Market Up 2.8% in MAT Q2/2018
Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Mar...
SAMR Solicits Comments on Production Licensing Regulation fo...
Merck KGaA Paves the Way for its Innovation Hub in Southern ...
Performance of Chinese Pharmaceutical Industry on Steady Gro...
Amyris Further Expands Relationship with Yifan Pharma
Ascendis Forms Chinese JV for Endocrinology Rare Disease The...
NMPA Issues Guidelines for Clinical Trials of Mental and...
NMPA Issues New Announcement (2018#86) for Clinical Data...
Shanghai Promotes Biopharma Innovation with New Measures...
CDE Issues Notice Over Change of Priority Review Publica...
NMPA Releases List of Reference Formulations for Generic...
SAMR Solicits Comments on Vaccine Administration Law
Chinese Lawyer Sues Yunnan Baiyao over False Advertising
Genentech Accuses Former Employees of Stealing Drug Secrets ...
Changchun Changsheng Biotech Fined CNY 9.1B in Vaccine Scand...
New U.S. Rules on Foreign Investment to Curb Chinese Goldrus...
Huahai Pharma Faces Lawsuits on Cancer-Causing Valsartan...
Zheijiang Huahai Placed under Increased Supervision
EU, U.S. and Canada Investigating Second Impurity in Hua...
EU Regulators Issue Notice on a Chinese Anticancer API A...
USFDA Recalls Thyroid Drugs Containing Chinese API over ...
BeiGene Announces Acceptance of Its NDA in China and Top...
Green Vally Reports Positive Results in Phase 3 China Tr...
CStone Receives USFDA IND Approval for PD-1 mAb CS1003
Reistone Biopharma to Initiate Its Ulcerative Colitis Ph...
Chi-Med Starts Phase I Study of HMPL-523 for Leukemia In...
Guangdong Introduces Implementation Plan for Generic Dru...
China Step Up Crackdown on Medical Frauds by Charities
China Step Up Crackdown on Medical Frauds by harities fa...
China Aims to Train 500,000 Additional GPs by 2030
NHC Releases 2018 Edition of National Essential Drug Lis...
Recent Executive Moves
Recent Executive Moves
SMIA Announces 17 Departmental Level Senior Official Appoi...
Recent Executive Moves
Top Chinese Pharma Tycoons Advance on Forbes China Rich Li...
China to Launch New Tech Bourse in Shanghai
Upcoming Event: 2nd International Conference on Vaccines...
Upcoming Event: 31st Annual Cardiologists Conference
Upcoming Event: Phar-East 2019
Upcoming Event: Health Insurance Innovation Congress Asi...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links